Article

US Chief Technology Officer Todd Park Leaving His Post

Todd Park, well-known in healthcare IT circles as a founder of Athenahealth and Castlight Health, is leaving his post as White House chief technology officer by year-end, Fortune is reporting..

Todd Park, well-known in healthcare IT circles as a founder of Athenahealth and Castlight Health, is leaving his post as White House chief technology officer by year-end,

.

Fortune is reporting.

Park became chief technology officer at HHS in 2009 and moved up to his current post in 2012, assuming a

made to

after its troubled launch.

Source: ModernHealthcare

Read the full story:

lead role in the fixesHealthCare.gov

http://bit.ly/1mvYn6l

Related Videos
Screenshot of an interview with Nadine Barrett, PhD
Female doctor in coat with stethoscope on blue background - Pixel-Shot - stock.adobe.com
Anna-Maria Hoffmann-Vold, MD, PhD, a senior consultant and leader of inflammatory and fibrotic research area at Oslo University Hospital
Io Hui, PhD, researcher at The University of Edinburgh
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
Related Content
3D ovarian cancer illustration | Image Credit: Dr_Microbe - stock.adobe.com
October 15th 2024

Mirvetuximab Soravtansine Effective in Patients With FRα+, Platinum-Sensitive Ovarian Cancer

Brooke McCormick
The phase 2 PICCOLO trial demonstrated that mirvetuximab soravtansine (Elahere; AbbVie) is effective and tolerable in heavily pre-treated patients with folate receptor alpha-positive (FRα+), platinum-sensitive ovarian cancer.
managed care cast logo
October 3rd 2024

Dr Rick Chapman Discusses Key Insights From the Center’s Rare Disease Project

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the chief science officer of the Center for Innovation & Value Research about key insights from its Rare Disease project.
Market share increase | Image Credit: Kiattisak - stock.adobe.com
October 15th 2024

Samsung Bioepis Reports 2024 Biosimilar Market Growth Trends

Cameron Santoro
Adalimumab biosimilar market shares have steadily increased, but challenges remain due to pricing strategies and limited government support, according to the Samsung Bioepis report.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024

Sustaining Compassionate Trauma Care Across Communities

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
COPD illustration | Image Credit: peterschreiber.media - stock.adobe.com
October 15th 2024

Ineligibility, Limitations to PR Uptake in Patients With AECOPD

Brooke McCormick
Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Woman at heart doctor | Image credit: Seventyfour – stock.adobe.com
October 15th 2024

Why Are We Still Seeing Gaps in Women’s Heart Care?

Hayden E. Klein
Women are still being excluded from cardiovascular research trials, and it has a lasting impact on heart disease treatment for women today.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo